Ablacon, Inc.

FDA Regulatory Profile

Ablacon, Inc. appears in FDA public data with 0 recalls, 3 510(k) clearances, 0 FDA inspections, and 0 compliance actions on record. Its most recent 510(k) clearance was granted on June 8, 2023.

Summary

Total Recalls
0
510(k) Clearances
3
Inspections
0
Compliance Actions
0

Recent 510(k) Clearances

K-NumberDeviceDate
K230008Ablamap® SystemJune 8, 2023
K223666Ablacath™ Mapping CatheterMarch 17, 2023
K203084Ablamap SoftwareAugust 31, 2021